Author:
Burton Jodie M.,O’Connor Paul
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Neuroscience
Reference51 articles.
1. Vollmer T: Patient use of and compliance to disease modifying agents for MS. Paper presented at the Consortium of Multiple Sclerosis Centers Annual Meeting. Baltimore, MD; June 2002.
2. IFNB Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993, 43:655–661.
3. Jacobs L, Cookfair D, Rudick R, et al.: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996, 39:285–294.
4. PRISMS Study Group: Randomized double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 1998, 352:1498–1504.
5. Johnson K, Brooks B, Cohen J, et al.: Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995, 45:1268–1276.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献